US HB1849 | 2015-2016 | 114th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 5-1)
Status: Introduced on April 16 2015 - 25% progression, died in committee
Action: 2015-04-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 16 2015 - 25% progression, died in committee
Action: 2015-04-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2015 Amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to establish and implement a hereditary hemorrhagic telangiectasia (HHT, a genetic vascular bleeding disorder that causes abnormalities of the blood vessels) initiative to improve early detection, screening, and treatment of people who suffer from HHT, focusing on advancing HHT research and increasing physician and public awareness of HHT. Directs HHS to establish the HHT Coordinating Committee to develop and coordinate implementation of a plan to advance research and understanding of HHT, including by conducting or supporting research at the National Institutes of Health (NIH) and making recommendations regarding NIH research grants relating to HHT. Requires the Centers for Disease Control and Prevention to carry out activities with respect to HHT, including conducting surveillance and establishing an HHT resource center to provide comprehensive education on and disseminate information about HHT to health professionals, patients, industry, and the public. Requires the Centers for Medicare & Medicaid Services to award grants for HHT research, including an analysis of health care expenditures associated with untreated HHT and costs associated with preventable medical events among Medicare beneficiaries with HHT.
Title
Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2015
Sponsors
Rep. Edward Royce [R-CA] | Rep. James Himes [D-CT] | Rep. Rosa DeLauro [D-CT] | Rep. Zoe Lofgren [D-CA] |
Rep. Eleanor Norton [D-DC] | Rep. David Loebsack [D-IA] |
History
Date | Chamber | Action |
---|---|---|
2015-04-29 | House | Referred to the Subcommittee on Health. |
2015-04-17 | House | Referred to the Subcommittee on Health. |
2015-04-16 | House | Referred to House Ways and Means |
2015-04-16 | House | Referred to House Energy and Commerce |
2015-04-16 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2015-04-16 | House | Introduced in House |
Subjects
Advisory bodies
Cardiovascular and respiratory health
Health
Health care costs and insurance
Health facilities and institutions
Health information and medical records
Health programs administration and funding
Hereditary and development disorders
Medical research
Medical tests and diagnostic methods
Medicare
Research administration and funding
Cardiovascular and respiratory health
Health
Health care costs and insurance
Health facilities and institutions
Health information and medical records
Health programs administration and funding
Hereditary and development disorders
Medical research
Medical tests and diagnostic methods
Medicare
Research administration and funding
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/114th-congress/house-bill/1849/all-info |
Text | https://www.congress.gov/114/bills/hr1849/BILLS-114hr1849ih.pdf |